Feasibility Study of an Online Physical Activity Intervention for Youth With Depression

A Feasibility Study Evaluating an Online Physical Activity Intervention for Young Adults With Low Mood and/or Depression Engaged in Community Primary Clinical Care

Physical activity (PA) has recently been established as both a primary intervention for mild to moderate, and a secondary therapy for moderate to severe Major Depressive Disorder (MDD; Fortier et al., 2020). Those with mental health disorders do not on average achieve recommended levels of PA (Hallgren et al., 2016), and exercise prescription is extremely lacking in clinical care (Stanton, Reaburn, & Happell, 2015; Stanton et al., 2018). Theory-based behavioural interventions have proven to be an effective tool for improving physical activity levels in clinical populations (Glowacki, et al., 2017; Stanton et al., 2015). More research is needed to understand PA intervention effectiveness for MDD patients (Glowacki et al., 2017), support integration of such behavioural treatments with primary care (Lederman et al., 2017), and address growing concerns regarding mental health during the global pandemic and beyond (Boyce, 2021). This community-based study examines the feasibility of a co-designed, 10-week, asynchronous, web-based beta platform PA intervention for patients with experience of low mood and/or mild to moderate depression, and will provide important parameters for a future randomized-controlled trial (RCT). Primary outcome measures will focus on acceptability and feasibility, including recruitment and retention rates. Secondary measures will include physical activity and depression symptom severity. Behavioural predictors of PA are to be evaluated as tertiary outcomes. Questionnaires will include an adapted participant experience measure, Godin Leisure-Time Exercise Questionnaire, and the Patient Health Questionnaire-9. This study features a controlled baseline, post-intervention evaluative design with an embedded quantitative process evaluation with a waitlist control. Participants will be young adults with experience of low mood and/or mild to moderate depression, 19-30 years of age, with access to a device with internet, English speaking, living within British Columbia, CAN., and falling below the minimum Canadian recommendations for PA. Study recruitment will primarily be facilitated by multiple youth mental health primary and community care clinics. This study will contribute to understanding of acceptable, efficacious, behaviour-based and mobile health intervention approaches for young adults with depression. It will also provide young people with a platform to share invaluable feedback to direct innovations in their own alternative care and mental health treatment. If outcome benchmarks set based on previous literature are met or exceeded for each of recruitment, retention, and acceptability, and depressive symptoms trend downwards for intervention participants, then a future randomized controlled trial exploring principally mental health outcomes will be recommended.

Study Overview

• Status: Completed
• Conditions: Moderate Depression; Inactivity, Physical; Low Mood; Mild Depression
• Intervention / Treatment: Behavioral: physical activity

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Aleah B Ross, BSc; Phone Number: 1-778-679-3379; Email: rossa382@uvic.ca

Study Locations

• Canada
  • British Columbia
    • Victoria, British Columbia, Canada, V8P 5C2
      • University of Victoria

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 19 years to 30 years (Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• between the ages of 19-30 years
• experience of low mood and/or mild to moderate depression (no diagnosis required)
• report falling below minimum Canadian public health recommendations for PA consistently over the past 6 months
• report no contraindications to physical activity (based on the completion of the Physical Activity Readiness Questionnaire administered at screening)
• do not report any manic or psychotic episodes within the past 6 months
• do not report any substance or alcohol abuse within the past 6 months
• have access to a device with an internet connection
• reside in British Columbia currently
• fluent in English

Exclusion Criteria:

• be young adults, 19-30 years of age,
• currently reside in British Columbia,
• self-identify as someone with experience of depression (ranging from low mood and/or depressive symptoms to a formal mild to moderate Major Depressive Disorder diagnosis according to the Diagnostic and Statistical Manual of Mental Health Disorders-V)
• report no manic episode(s) or psychosis in the past 6 months,
• fall below the minimum Canadian public health recommendations for PA (Ross et al., 2020) for at least six months prior to screening,
• have access to a device with internet access, AND
• English speaking.

No exclusion criteria for sex, gender, medications, race or religion will be applied. There will be no contraindications to PA after screening with the Physical Activity Readiness Questionnaire (PAR-Q).

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Intervention; An online, asynchronous, self-paced, 10-week long, physical activity intervention.	Behavioral: physical activity; A series of 10 weekly psychoeducational modules including information on psychosocial determinants of physical activity engagement, adherence and maintenance, as well as a number of other behaviour change tools, like reflection activities.
No Intervention: Control; A waitlist control; continue with life/activity as usual. Control participants will receive access to the intervention at 10 weeks following all measurements.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Recruitment Rate	outcome related to trial feasibility	10 weeks
Retention Rate	outcome related to trial feasibility	10 weeks
Experience Measure	outcome related to trial acceptability	10 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Depression Severity	measured with the Patient Health Questionnaire-9 (min.=0, max.=27, lower scores indicate fewer symptoms of depression)	10 weeks
Physical Activity Levels	measured with the Godin Leisure Time Exercise Questionnaire (min.=0, max.=N/A, higher scores indicate increased physical activity)	10 weeks

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Psychosocial Factors Predicting Physical Activity Behaviour	measured with the Multi-Process Action Control Framework which included various constructs and measurements scales, e.g., affective and instrumental attitude (min.=1, max.=7, higher scores indicate increased positively-valenced attitude; Ajzen 2002; Rhodes and Courneya 2003)	10 weeks

Collaborators and Investigators

• Sponsor: University of Victoria
• Investigators: Principal Investigator: Ryan E Rhodes, PhD, University of Victoria; Study Director: Aleah B Ross, BSc, University of Victoria

Study record dates

Study Major Dates

• Study Start (Actual): February 22, 2022
• Primary Completion (Actual): November 24, 2023
• Study Completion (Actual): November 24, 2023

Study Registration Dates

• First Submitted: May 18, 2022
• First Submitted That Met QC Criteria: May 18, 2022
• First Posted (Actual): May 23, 2022

Study Record Updates

• Last Update Posted (Actual): December 26, 2023
• Last Update Submitted That Met QC Criteria: December 22, 2023
• Last Verified: November 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Behavioral Symptoms; Mental Disorders; Mood Disorders; Depression; Depressive Disorder
• Other Study ID Numbers: 21-0301

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No